期刊
CELL CYCLE
卷 21, 期 15, 页码 1543-1556出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2022.2060641
关键词
Mesenchymal stem cells; amniotic membrane; culture; isolation; stem cell markers
类别
资金
- Qatar National Library
The successful translation of MSCs from bench to bedside relies on their regenerative capabilities and immunomodulatory potential. Adult tissue-derived MSCs face challenges in sourcing and characterization, while alternative sources, such as amniotic membrane, offer advantages for clinical applications with optimized culture methods.
The successful translation of mesenchymal stem cells (MSCs) from bench to bedside is predicated upon their regenerative capabilities and immunomodulatory potential. Many challenges still exist in making MSCs a viable and cost-effective therapeutic option, due in part to the challenges of sourcing MSCs from adult tissues and inconsistencies in the characterization of MSCs. In many cases, adult MSC collection is an invasive procedure, and ethical concerns and age-related heterogeneity further complicate obtaining adult tissue derived MSCs at the scales needed for clinical applications. Alternative adult sources, such as post-partum associated tissues, offer distinct advantages to overcome these challenges. However, successful therapeutic applications rely on the efficient ex-vivo expansion of the stem cells while avoiding any culture-related phenotypic alterations, which requires optimized and standardized isolation, culture, and cell preservation methods. In this review, we have compared the isolation and culture methods for MSCs originating from the human amniotic membrane (hAMSCs) of the placenta to identify the elements that support the extended subculture potential of hAMSCs without compromising their immune-privileged, pluripotent regenerative potential.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据